Michael A. Gesser - 08 Nov 2021 Form 4 Insider Report for ACORDA THERAPEUTICS INC

Role
Chief Financial Officer
Signature
/s/ Michael A. Gesser
Issuer symbol
N/A
Transactions as of
08 Nov 2021
Net transactions value
$0
Form type
4
Filing time
09 Nov 2021, 18:11:05 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACOR Employee Stock Option (right to buy) Award $0 +85,000 $0.000000 85,000 08 Nov 2021 Common Stock 85,000 $3.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options issued under the issuer's 2016 Inducement Plan. Twenty-five percent of the shares subject to the options vest on November 8, 2022. The balance of the shares vest in equal quarterly installments over the three years thereafter.